skip to content
Home

Cambridge Immunology Network

 

Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection

Submitted by J.M. Arasteh on Fri, 05/02/2021 - 10:55

SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists.

Read the original article here>

Contact us

Cambridge Immunology Network Coordinator

University of Cambridge Department of Medicine,
Jeffrey Cheah Biomedical Centre,
Cambridge Biomedical Campus, Puddicombe Way,
Cambridge, CB2 0AW

Contact: webmaster@immunology.cam.ac.uk

Site Privacy & Cookie Policies

 Follow us on Twitter

Watch our webinars

Sign up to our newsletter

We are a FOCIS centre of Excellence

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more

Study at Cambridge

About the University

Research at Cambridge